Gizmodo logo
CNN logo
Semafor logo
3 articles
·2M

Colossal Secures $120 Million to Advance Dodo Bird Revival Project

Colossal has successfully raised $120 million in funding, marking a significant milestone in its ambitious scientific endeavor to revive the extinct dodo bird species.

Subscribe to unlock this story

We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!

Get Started

Have an account? Sign in

Overview

A summary of the key points of this story verified across multiple sources.

  • Colossal, a pioneering biotechnology company, has successfully secured $120 million in new funding to further its groundbreaking de-extinction initiatives.
  • This substantial financial injection represents a critical milestone for the company, bolstering its capacity to pursue complex genetic engineering projects.
  • A primary focus of Colossal's efforts, supported by this funding, is the ambitious project aimed at bringing the iconic dodo bird back from extinction.
  • The funding will enable Colossal to accelerate research and development, utilizing advanced genetic technologies to recreate the dodo's genetic blueprint.
  • This significant investment underscores growing interest and confidence in the potential for scientific advancements to restore extinct species and biodiversity.
Written by AI using shared reports from
3 articles
.

Report issue

Pano Newsletter

Read both sides in 5 minutes each day

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Center-leaning sources cover this story neutrally, focusing on reporting Colossal Biosciences' scientific milestones in dodo de-extinction. They detail the company's progress, explain the scientific methods, and include both praise and criticism from other scientists regarding the 'de-extinction' label, allowing the company to respond to these critiques.

"Colossal Biosciences announced this week several milestones in its quest to bring the extinct species back to life."

GizmodoGizmodo
·2M
Article

"It is a historic step in bringing the dodo bird, extinct for more than 360 years, back to life."

SemaforSemafor
·2M
Article

Articles (3)

Compare how different news outlets are covering this story.

FAQ

Dig deeper on this story with frequently asked questions.

Colossal uses advanced genetic engineering and CRISPR genome editing technologies to recreate the genetic blueprint of extinct species, including the dodo bird.

Colossal Biosciences was founded in 2021 by Harvard geneticist George Church and entrepreneur Ben Lamm.

Besides the dodo bird, Colossal aims to de-extinct animals such as the woolly mammoth, Tasmanian tiger, northern white rhinoceros, and dire wolf.

Colossal considers de-extinction essential for restoring lost biodiversity and reintroducing species that play critical roles in climate-beneficial ecosystems, helping to reverse human-caused environmental degradation.

Colossal recently secured $120 million specifically for the dodo bird revival project, in addition to prior funding rounds totaling over $435 million and $200 million in Series C funding, valuing the company at $10.2 billion as of early 2025.

History

See how this story has evolved over time.

  • This story does not have any previous versions.